Endometrioma Related Reduced Ovarian Reserve
ERROR
The Effect Of The Presence Of Endometriomas On Ovarian Reserve
1 other identifier
observational
80
1 country
1
Brief Summary
Prior studies have shown surgical excision of endometriomas are associated with a decline in ovarian reserve as assessed by serum anti-Mullerian Hormone (AMH) levels. However, the natural history of serum AMH levels in the presence of untreated endometriomas are unknown. Purpose of this study is to determine whether the presence of endometriomas cause a faster decline in serum AMH levels than in healthy women over a six months period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 6, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedDecember 19, 2017
December 1, 2017
2.3 years
May 6, 2015
December 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Serum Anti- mullerian hormone (AMH) level
at recruitment and six months later
Study Arms (3)
Endometrioma
Reproductive aged women diagnosed with endometrioma. Conservative follow up for six months.
Healthy Controls
Women with regular menstrual cycles and without ovarian pathology will be recruited from physicians, nurses and other staff of the same hospital. Controls will be matched for age with the women in the endometrioma group. They will be conservatively followed up for six months.
Historical controls who underwent surgical excision
20 women who underwent surgical excision of endometrioma in the same clinic had serum AMH levels measured preoperatively and on post operative sixth month. Their values will be compared with that of endometrioma group. These data were priorly published in detail (Uncu et al. 2013).
Interventions
Eligibility Criteria
The decision to include a healthy control group was taken five months after starting recruitment of women with endometrioma. Only 12 women with endometriomas had been recruited until then and none of them had six month serum AMH level measured. Since healthy controls were reluctant to undergo transvaginal ultrasound examination, antral follicle counts were not measured as another marker of ovarian reserve for healthy controls and some women in the endometrioma group.
You may qualify if:
- Reproductive age
- Endometrioma without indication for surgery or treatment with combined contraceptive, progestin or other hormonal intervention.
You may not qualify if:
- Menstrual cycle irregularity
- Polycystic ovarian syndrome
- Women who were pregnant or contemplating pregnancy in the next six months
- History of ovarian surgery
- Using medication which could affect ovarian function during six months before recruitment
- Indication for surgical excision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uludag University Scholl of medicine
Bursa, Turkey/bursa, Turkey (Türkiye)
Related Publications (2)
Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013 Aug;28(8):2140-5. doi: 10.1093/humrep/det123. Epub 2013 Apr 26.
PMID: 23624580BACKGROUNDKasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, Uncu G. Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018 Jul 1;110(1):122-127. doi: 10.1016/j.fertnstert.2018.03.015. Epub 2018 Jun 20.
PMID: 29935810DERIVED
Biospecimen
Serum Anti-mullerian hormone (AMH)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
gürkan uncu
Uludag University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof.md
Study Record Dates
First Submitted
May 6, 2015
First Posted
May 8, 2015
Study Start
April 1, 2015
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
December 19, 2017
Record last verified: 2017-12